C Diff Vaccine Shows Lot Consistency, Induces Toxin A and B

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.

Related Keywords

Shane Christensen , J Lewis Research , Foothill Family Clinic , Ccdi , C Diff , Clostridioides Difficile , Vaccine , Antibody Response , Toxin A , Toxin B , Immunogenicity , Consistency ,